Core Scientific Inctx
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
CORZ$12.72+8.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Financial Statements and Supplementary Data
Our consolidated financial statements and the notes thereto, included in Part IV, Item 15(1)(a) herein, are incorporated by reference into this Item 8.
CONSOLIDATED FINANCIAL STATEMENT TABLE OF CONTENTS
| Report of Independent Registered Public Accounting Firm (PCAOB ID 688) | 74 | |
|---|---|---|
| Consolidated Balance Sheets | 76 | |
| Consolidated Statements of Operations | 77 | |
| Consolidated Statements of Comprehensive Loss | 78 | |
| Consolidated Statements of Changes in Contingently Redeemable Convertible Preferred Stock and Stockholders’ Deficit | 79 | |
| Consolidated Statements of Cash Flows | 81 | |
| Notes to Consolidated Financial Statements | 84 | |
| 1 — Organization and Description of Business | 84 | |
| 2 — Summary of Significant Accounting Policies | 85 | |
| 3 — Chapter 11 Filing and Emergence from Bankruptcy | 93 | |
| 4 — Business Combination and Restructuring | 100 | |
| 5 — Property, Plant, and Equipment | 102 | |
| 6 — Balance Sheet Components | 103 | |
| 7 — Leases | 104 | |
| 8 — Convertible and Other Notes Payable | 107 | |
| 9 — Contingent Value Rights and Warrant Liabilities | 117 | |
| 10 — Fair Value Measurements | 120 | |
| 11 — Commitments and Contingencies | 122 | |
| 12 — Stockholders' Deficit | 124 | |
| 13 — Income Taxes | 130 | |
| 14 — Net Loss Per Share | 132 | |
| 15 — Segment Reporting | 133 | |
| 16 — Related Party Transactions | 137 | |
| 17 — Subsequent Event | 137 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.